Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Risk Factors
Polymorphisms in vitamin D receptor may mediate breast cancer risk
December 8th, 2005
Polymorphisms in the vitamin D receptor may mediate breast cancer risk. According to recent research from the United States, "Biological and epidemiologic data suggest that vitamin D levels may influence breast cancer development. The vitamin D receptor (VDR) is a crucial mediator for the cellular effects of vitamin D and additionally interacts with other cell-signaling pathways that influence cancer development." "Because functional data exist on FOK1 and previous studies have suggested a relation between BSM1 and breast cancer risk," W. Y. Chen and colleagues "evaluated the associations of the FOK1 and BSM1 VDR polymorphisms and breast cancer risk....
Source: Women's Health Weekly (2005-12-08)
|
